Articles | Open Access | https://doi.org/10.37547/ijmscr/Volume02Issue12-03

PRE-CLINICAL STUDIES OF THE ANTITUBERCULOUS DRUG BIOMAYRIN

Mamatmusaeva N.E. , Institute Of Bioorganic Chemistry, Academy Of Sciences Of Uzbekistan, Uzbekistan, Tashkent City,Mirzo Ulugbek St. 83, Uzbekistan
Shomuratov Sh.А. , Institute Of Bioorganic Chemistry, Academy Of Sciences Of Uzbekistan, Uzbekistan, Tashkent City,Mirzo Ulugbek St. 83, Uzbekistan
Sagdullaev B.Т. , Institute Of Bioorganic Chemistry, Academy Of Sciences Of Uzbekistan, Uzbekistan, Tashkent City,Mirzo Ulugbek St. 83, Uzbekistan
Turaev А.S. , Institute Of Bioorganic Chemistry, Academy Of Sciences Of Uzbekistan, Uzbekistan, Tashkent City,Mirzo Ulugbek St. 83, Uzbekistan

Abstract

By chemical modification of polygalacturonic acid with anti-TB drugs isoniazid, ethambutol and rifampicin, the macromolecular system Biomayrin was obtained. Pharmaco-toxicological studies have ascertained that Biomayrin is less toxic than low-molecular counterparts and has pronounced anti-tuberculosis activity, and with a two-fold lower dose when calculating the active substance, it has identical activity with the combined anti-tuberculosis drug Mayrin. Pharmacokinetic studies have shown that with the introduction of Biomayrin, the therapeutic concentration of the active ingredients (isoniazid, ethambutol and rifampicin) in the blood lasts longer than that of their low-molecular counterparts. It should also be noted that the chemical binding of isoniazid to the polysaccharide matrix slows down its metabolism to therapeutically inactive acetylisoniazid.

Keywords

Polygalacturonic acid, isoniazid, ethambutol, rifampicin

References

Khomenko A.G. Modern chemotherapy of tuberculosis // Clinical pharmacology and therapy. 1998. № 4. P. 16-20.

Strachunsky L.S., Kozlov S.N. Modern antimicrobial chemotherapy. A guide for doctors. - M.: Borges, 2002. – P. 432.

Application for patent IAP 20160219 dated 07/06/2016 Shomurotov Sh.A., Akhmedov O.R., Turaev A.S. "Combined long-acting anti-TB drug."

Recommendation for laboratory diagnosis of tuberculosis. Omsk, 1988. – P.64.

Yaschenko T.N. Mecheva I.S. Manual of laboratory tests for tuberculosis. – M.: Medicine, 1973. – P. 53-77.

Methodical recommendations for preclinical study of the general toxic effect of drugs. / Guidelines for conducting preclinical studies of drugs. Part one. P.13-23 // ed. Mironova A.N.- M.-2012. - p.944

“Encyclopedia of medicines” 2017. Register of medicines of Russia. 25th edition.

Slivkin A.I., Selemenev V.F., Sukhoverkhova Ye.A. (1999) Physico-chemical and biological methods for assessing the quality of medicines. Voronezh: VSU,. 215-218.

Laboratory of Applied Pharmacokinetics (1995) USC * Pack P.C. Collection Clinical Research Programs. Los Angeles. University of Southern California. School of Medicine. Version 10.7.

Article Statistics

Copyright License

Download Citations

How to Cite

Mamatmusaeva N.E., Shomuratov Sh.А., Sagdullaev B.Т., & Turaev А.S. (2022). PRE-CLINICAL STUDIES OF THE ANTITUBERCULOUS DRUG BIOMAYRIN. International Journal of Medical Sciences And Clinical Research, 2(12), 09–20. https://doi.org/10.37547/ijmscr/Volume02Issue12-03